Abstract
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain reluctant to treat PWID. The aim of this review was to investigate sustained virologic response (SVR), adherence, discontinuation, and HCV reinfection among PWID. A search of Medline, Embase, and Cochrane databases (between 2002 and January 2012) was conducted for primary articles/conference abstracts examining HCV treatment outcomes in PWID. Meta-analysis was used to obtain pooled estimates of SVR, adherence, discontinuation, and HCV reinfection.
Original language | English |
---|---|
Pages (from-to) | S80-89 |
Number of pages | 10 |
Journal | Clinical Infectious Diseases |
Volume | 53 |
Issue number | Suppl 2 |
DOIs | |
Publication status | Published - Aug 2013 |
Keywords
- hepatitis C virus
- drug users
- sustained virologic response
- virus infection